Compare · ALB vs ASPI
ALB vs ASPI
Side-by-side comparison of Albemarle Corporation (ALB) and ASP Isotopes Inc. (ASPI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALB and ASPI operate in Major Chemicals (Industrials), so they compete in similar markets.
- ALB is the larger of the two at $12.13B, about 27.7x ASPI ($438.5M).
- Over the past year, ALB is up 4.9% and ASPI is down 70.0% - ALB leads by 74.9 points.
- Both names hit the wire about 6 times in the past 4 weeks.
- ALB has more recent analyst coverage (25 ratings vs 3 for ASPI).
- Company
- Albemarle Corporation
- ASP Isotopes Inc.
- Price
- $101.19-0.91%
- $2.66-5.67%
- Market cap
- $12.13B
- $438.5M
- 1M return
- -17.18%
- -26.11%
- 1Y return
- +4.91%
- -69.99%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- News (4w)
- 6
- 6
- Recent ratings
- 25
- 3
Albemarle Corporation
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Latest ALB
- Director Wolff Alejandro Daniel was granted 45 shares, increasing direct ownership by 0.34% to 13,089 units (SEC Form 4)
- Albemarle Corporation to Release Third Quarter 2026 Earnings Results on Wednesday, November 4, 2026
- SEC Form SD filed by Albemarle Corporation
- Chief Commercial Officer Norris Eric was granted 10,867 shares, increasing direct ownership by 20% to 64,310 units (SEC Form 4)
- Chief Operations Officer Mummert Mark Richard was granted 6,086 shares, increasing direct ownership by 35% to 23,601 units (SEC Form 4)
- Chief People Officer Gagarinas Autumn M. was granted 5,217 shares, increasing direct ownership by 97% to 10,610 units (SEC Form 4)
- Chief Accounting Officer Hood Max was granted 1,476 shares (SEC Form 4)
- Albemarle Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Albemarle Announces CEO Succession Plan
- SEC Form 3 filed by new insider Hood Max
Latest ASPI
- SEC Form 3 filed by ASP Isotopes Inc.
- SEC Form SCHEDULE 13D filed by ASP Isotopes Inc.
- ASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Director Ryan Robert John Andrew bought $40,200 worth of shares (15,000 units at $2.68), increasing direct ownership by 2% to 675,222 units (SEC Form 4)
- Director Ryan Robert John Andrew bought $21,600 worth of shares (8,000 units at $2.70), increasing direct ownership by 1% to 660,222 units (SEC Form 4)
- SEC Form 144 filed by ASP Isotopes Inc.
- COO Ainscow Robert sold $36,216 worth of shares (8,438 units at $4.29) as part of a pre-agreed trading plan, decreasing direct ownership by 0.37% to 2,248,441 units (SEC Form 4) (withholding tax)
- SEC Form 425 filed by ASP Isotopes Inc.
- SEC Form 425 filed by ASP Isotopes Inc.
- ASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits